Holding(s) in Company

BowLeven Plc
05 February 2007


                                                                    

 

TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES

 

(1). Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached (ii):

Bowleven Plc

 

2. Reason for the notification (please tick the appropriate box or boxes):


 

An acquisition or disposal of voting rights:                               (   )


 

An acquisition or disposal of financial instruments which may result 
in the acquisition of shares already issued to which voting rights are 
attached:                                                                  (   )


 

An event changing the breakdown of voting rights:                          (   )



                                                                           
Other (please specify) :                                                   ( x )

.................

 

3. Full name of person(s) subject to the notification obligation (iii):

GSK Common Investment Fund

 

4. Full name of shareholder(s) (if different from 3.) (iv):

.................

 

5. Date of the transaction and date on which the threshold is crossed or reached
if different) (v):

N/A

 

6. Date on which issuer notified:

5th February 2007

 

7. Threshold(s) that is/are crossed or reached:

Below 3%

 

8. Notified details:

.................

 

 

 

A: Voting rights attached to shares

 
Class/type of shares            Situation previous to  
if possible using the           the Triggering         
ISIN CODE                       transaction (vi)       
                       Number of shares       Number of voting Rights 
                                              (viii)                  
                                                                      
                                                                      
GB00B04PYL99           2,191,011              2,191,011                                                                 
                       (3.62%)                (3.62%)                                        
                     
 

                     Resulting situation after the triggering transaction (vii)

 
Class/type of shares Number of shares  Number of voting rights    % of voting rights  
if possible using                      (ix)                                           
the ISIN CODE                                                                         
                     Direct            Direct (x) Indirect (xi)   Direct    Indirect  
                                                                                      
                     2,191,011         2,191,011     N/A          2.98%     N/A                                    
                                                                                      

 

B: Financial Instruments

Resulting situation after the triggering transaction (xii)

 
Type of     Expiration Date  Exercise/Conversion Number of voting     % of voting     
financial   (xiii)           Period/ Date (xiv)  rights that may be   rights          
instrument                                       acquired if the                      
                                                 instrument is                        
                                                 exercised/                           
                                                 converted.                           
                                                                                      
                                                                                      

 

 

Total (A+B)
Number of voting     % of voting rights 
rights                                  
                                        
                                        
2,191,011            2.98%                            

 

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable (xv):

.................

 

Proxy Voting:

 

10. Name of the proxy holder:

.................

 

11. Number of voting rights proxy holder will cease to hold:

.................

 

12. Date on which proxy holder will cease to hold voting rights:

.................

 

13. Additional information:

.................

 

14. Contact name:

.................

 

15. Contact telephone number:

.................

 

 

Annex Notification Of Major Interests In Shares (XVI)

 

A: Identity of the person or legal entity subject to the notification obligation

 

Full name (including legal form for legal entities):

GSK Common Investment Fund

 

Contact address (registered office for legal entities):

33 King William Street, London, EC4R 9AS

 

Phone number:

020 7743 2098

 

Other useful information (at least legal representative for legal persons):

Thomas Hone

 

B: Identity of the notifier, if applicable (xvii)

 

Full name:

Karen Fraser

 

Contact address:

.................

 

Phone number:

0131 260 5109

 

Other useful information (e.g. functional relationship with the person or legal
entity subject to the notification obligation):

.................

 

C: Additional information :

.................

 

 




                      This information is provided by RNS
            The company news service from the London Stock Exchange